Use of Inotropic Agents in Patients with Advanced Heart Failure: Lessons from Recent Trials and Hopes for New Agents

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.5, 2011-03, pp. : 515-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Inotropic Agents: Milrinone Analogs

By Dorigo P. Fraccarollo D. Gaion R.M. Santostasi G. Borea P.A. Floreani M. Mosti L. Maragno I.

General Pharmacology, Vol. 28, Iss. 5, 1997-05 ,pp. : 781-788

Elsevier

Access to resources Recommend Favorite

Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1519-1530

Bentham Science Publishers

Access to resources Recommend Favorite

Calcium Sensitising Agents in Heart Failure

By Mathew L. Katz S.D.

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 191-204

Adis International

Access to resources Recommend Favorite

Agents targeting inflammation in heart failure

By Gullestad Lars Kjekshus John Damås Jan Kristian Ueland Thor Yndestad Arne Aukrust Pål

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 557-566

Informa Healthcare

Access to resources Recommend Favorite

-Blockade in Heart Failure: Selective Versus Nonselective Agents

By Metra M. Nodari S. Dei Cas L.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 1, 2001-01 ,pp. : 3-14

Adis International

Access to resources Recommend Favorite